SecBot SecBot

Block, Report, And Suspend Suspicious Shipments Act

H.R. 501 Rep. Diana Harshbarger (R-TN-1) In committee
Bill text PDF
  1. Introduced Jan 25
  2. Committee Jan 25
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jan 25, 2023Next: House vote
1260d ago May 17, 2023: Placed on the Union Calendar, Calendar No. 46.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 1 filing
Subscribe to see spend
Member trades
2trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Medical Devices & Healthcare 1
Search all 1 companies, their asks and price moves Subscribe

Summary

Block, Report, And Suspend Suspicious Shipments Act

Full summary4 paragraphs

This bill creates additional requirements for drug manufacturers and distributors who discover a suspicious order or series of suspicious orders for controlled substances.

Currently, a manufacturer or distributor must report a suspicious order or series of suspicious orders to the Drug Enforcement Administration (DEA). This bill also requires a manufacturer or distributor to exercise due diligence and decline to fill the order. However, if the manufacturer or distributor resolves all of the indicators giving rise to the suspicious order or series of suspicious orders, then the bill allows the manufacturer or distributor to fill the order and choose not to report it to the DEA.

A violation is subject to civil and criminal penalties under the Controlled Substances Act.

The DEA must issue regulations specifying the indicators that give rise to a suspicious order.

Library of Congress summary, Jan 25, 2023

Summary versions
  • Introduced in HouseJan 25, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.